4.32

4.60% 0.19

After Hours: 4.35 0.03 +0.69%

Psyence Biomedical Ltd (PBM)

Overview News Price History Discussions Forecast Stock Split

Psyence Biomedical Ltd stock is traded at $4.32, with a volume of 16,495. It is up +4.60% in the last 24 hours and down -28.83% over the past month. Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Previous Close:

$4.13

Open:

$4.09

24h Volume:

16,495

Relative Volume:

0.31

Market Cap:

$16.48M

Revenue:

Net Income/Loss:

$1.52M

P/E Ratio:

-0.6834

EPS:

-6.3213

Net Cash Flow:

$-1.14M

1W Performance:

-15.62%

1M Performance:

-28.83%

6M Performance:

+50.00%

1Y Performance:

-80.47%

1-Day Range:

$4.09

$4.44

1-Week Range:

$4.09

$5.205

52-Week Range:

$1.92

$22.96

Psyence Biomedical Ltd Stock (PBM) Company Profile

Name

Psyence Biomedical Ltd

Sector

Healthcare (1051)

Industry

Biotechnology (593)

Phone

Address

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

PBM's Discussions on Twitter

Compare PBM vs VRTX, MRNA, REGN, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PBM Psyence Biomedical Ltd	4.32	16.48M	0	1.52M	-1.14M	-6.3213
VRTX Vertex Pharmaceuticals Inc	508.75	128.95B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	236.50	94.42B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	796.34	81.99B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	846.27	53.22B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	374.08	42.32B	5.76B	514.49M	1.10B	4.4813

Psyence Biomedical Ltd Stock (PBM) Latest News

Oct 13, 2026

POM Stock Price, Quote & News - Syfe

Oct 13, 2026

Oct 05, 2026

A passive holder reports more than 5% of Psyence Biomedical (PBM) common shares. - stocktitan.net

Oct 05, 2026

Sep 29, 2026

Psyence Biomedical Warrant (PBMWW) Slides Nearly 20% to $0.02 as Sub-Penny Range TightensWave Alternation - https://www.dars.gov.et/

Sep 29, 2026

Sep 23, 2026

Psyence BioMed Agrees Up to $5 Million PsyLabs Investment and Forms Texas Ibogaine Unit - Yahoo Finance

Sep 23, 2026

Psyence BioMed invests up to $5M in PsyLabs, plans ibogaine trial By Investing.com - Investing.com Canada

Sep 23, 2026

Two companies agree to trade ownership stakes worth about $9 million apiece - Stock Titan

Sep 23, 2026

[6-K] PSYENCE BIOMEDICAL LTD. Current Report (Foreign Issuer) | PBM SEC FilingForm 6-K - Stock Titan

Sep 23, 2026

Psyence BioMed Announces Strategic Ibogaine Investment - GlobeNewswire

Sep 23, 2026

Psyence BioMed invests up to $5M in PsyLabs, plans ibogaine trial By Investing.com - Investing.com

Sep 23, 2026

Sep 11, 2026

Psyence Biomedical Ltd. Common Shares (NASDAQ: PBM) Stock Price, News & Analysis - kalkine.ca

Aug 19, 2026

Psyence Biomedical Ltd. Common Shares (NASDAQ: PBM) Stock Price, News & Analysis - Kalkine

Aug 19, 2026

Psyence BioMed Welcomes U.S. Administration's Latest Action to Accelerate Ibogaine Development - marketscreener.com

Aug 19, 2026

Aug 18, 2026

Psyence BioMed responds to Trump ibogaine announcement By Investing.com - Investing.com Canada

Aug 18, 2026

Psyence BioMed responds to Trump ibogaine announcement By Investing.com - Investing.com Nigeria

Aug 18, 2026

Psyence Biomedical stock surges on Trump ibogaine announcement By Investing.com - Investing.com Australia

Aug 18, 2026

Psyence (PBM) Session Recap: Closes 23.82% Higher at $4.47; Range and Risk: $4.25 and $4.69 Define the Nearby Reference Levels in the Latest ReadingSeasonality Effect - vinanet.vn

Aug 18, 2026

Psyence BioMed responds to Trump ibogaine announcement By Investing.com - Investing.com India

Aug 18, 2026

Psyence BioMed Welcomes White House Support for Accelerated U.S. Ibogaine Development - Quiver Quantitative

Aug 18, 2026

Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development - Yahoo Finance Singapore

Aug 18, 2026

Psyence Biomedical stock surges on Trump ibogaine announcement By Investing.com - Investing.com India

Aug 18, 2026

Psyence Biomedical stock surges on Trump ibogaine announcement By Investing.com - Investing.com Nigeria

Aug 18, 2026

Psyence Biomedical stock surges on Trump ibogaine announcement By Investing.com - Investing.com South Africa

Aug 18, 2026

Psyence Biomedical stock surges on Trump ibogaine announcement - Investing.com

Aug 18, 2026

Ibogaine could rise as potential psychedlic treatment with Trump announcement - Seeking Alpha

Aug 18, 2026

Psyence (PBM) Session Recap: Closes 23.82% Higher at $4.47; Range and Risk: $4.25 and $4.69 Define the Nearby Reference Levels in the Latest ReadingEarnings Breakout Stocks - dars.gov.et

Aug 18, 2026

Aug 15, 2026

Psyence Biomedical (PBM) Slips 2.25% to $3.48: Testing Support as Resistance HoldsLong Setup Ideas - vinanet.vn

Aug 15, 2026

Psyence Biomedical (PBM) Slips 2.25% to $3.48: Testing Support as Resistance HoldsPrice Surge Stocks - dars.gov.et

Aug 15, 2026

Aug 11, 2026

Psyence Biomedical (PBM) Slips 2.27% as Shares Test Key $3.40 LevelFactor Valuation - dars.gov.et

Aug 11, 2026

Psyence Biomedical (PBM) Slips 2.27% as Shares Test Key $3.40 LevelAAII Bullish - vinanet.vn

Aug 11, 2026